Deerfield Management Company »

Trimas Corporation shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Trimas Corporation (TRS) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Trimas Corporation

Tip: Access up to 7 years of quarterly data

All positions including Trimas Corporation held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trimas Corporation by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $555k 22k 25.33

More positions owned by Deerfield Management Company

Nuvalent Inc-a (NUVL)
Glaukos Corp Note 2.750% 6/1 (Principal)
Viatris (VTRS)
Invitae Corp Debt 4.500% 3/1 (Principal)
Natera Note 2.250% 5/0 (Principal)
Catalyst Pharmaceutical Partners (CPRX)
Centene Corporation (CNC)
Brookdale Sr Living Note 2.000%10/1 (Principal)
Insmed Note 1.750% 1/1 (Principal)
Neurocrine Biosciences (NBIX)
Accolade Note 0.500% 4/0 (Principal)
Oscar Health Cl A (OSCR)
Owens & Minor (OMI)
Adapthealth Corp Common Stock (AHCO)
Springworks Therapeutics (SWTX)

View all positions for Deerfield Management Company

Top funds holding Trimas Corporation

Vanguard Group
Fiduciary Management
Allspring Global Investments Holdings
Dimensional Fund Advisors
Wellington Management Company
Pzena Investment Management
River Road Asset Management
Massachusetts Financial Services
Franklin Resources
Charles Schwab Investment Management
Royal Bank of Canada
Bank of America Corporation
Barington Capital
Orchard Capital Managment
Millennium Management

View all funds holding Trimas Corporation